Medication Without Harm: WHO's Third Global Patient Safety Challenge
Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process. Medication errors occur when weak medication systems and/or human factors such as fatigue, poor environmental conditions or staff shortages affect prescribing, transcribing, dispensing, administration and monitoring practices, which can then result in severe harm, disability and even death. Multiple interventions to address the frequency and impact of medication errors have already been developed, yet their implementation is varied. A wide mobilization of stakeholders supporting sustained actions is required. In response to this, WHO has identified Medication Without Harm as the theme for the third Global Patient Safety Challenge.
Medication Without Harm: The third WHO Global Patient Safety Challenge will propose solutions to address many of the obstacles the world faces today to ensure the safety of medication practices. WHO’s goal is to achieve widespread engagement and commitment of WHO Member States and professional bodies around the world to reducing the harm associated with medication.
Medication Without Harm aims to reduce severe avoidable medication-related harm by 50%, globally in the next 5 years. It was formally launched at the Second Global Ministerial Patient Safety Summit in Bonn, Germany on 29 March 2017.
The Challenge is coordinated by the WHO Patient Safety and Quality Improvement unit, of the Service Delivery and Safety department, in collaboration with WHO department of Essential Medicines and Health Products.
For more information, download the Medication Without Harm brochure:
- Lancet Article: Medication Without Harm: WHO’s Third Global Patient Safety Challenge
- The third global patient safety challenge: tackling medication-related harm
- Essential medicines and health products
- Antimicrobial resistance
- Medicines safety and vigilance
- Rational use of medicines